Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 226 entries
View as:

Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT00162708 Org: User:
Start: 07/31/96 End: - Due: -

Engineering Immune Organoids to Study Pediatric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05890781 Org: User:
Start: 05/12/23 End: 05/31/28 Due: 05/31/29

Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03244956 Org: User:
Start: 12/27/17 End: 12/31/22 Due: 12/31/23

Radiofrequency Ablation of Lung Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00180856 Org: User:
Start: 01/31/02 End: - Due: -

Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II

Phase: N/A Priority: Normal
NCT ID: NCT02230176 Org: User:
Start: 02/28/15 End: 04/30/24 Due: 04/30/25

PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.

Phase: N/A Priority: Normal
NCT ID: NCT00180973 Org: User:
Start: 02/28/95 End: - Due: -

Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast

Phase: N/A Priority: Normal
NCT ID: NCT02666690 Org: User:
Start: 07/31/11 End: 10/31/13 Due: 10/31/14

Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006112 Org: User:
Start: 01/31/96 End: - Due: -

Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05180006 Org: User:
Start: 02/24/22 End: 02/28/26 Due: 02/28/27

Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02992912 Org: User:
Start: 11/15/16 End: 10/31/24 Due: 10/31/25

A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06508216 Org: User:
Start: 07/05/24 End: 12/17/27 Due: 12/17/28

Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00349505 Org: User:
Start: 09/30/04 End: - Due: -

Trial Of Pembrolizumab And Nintedanib

Phase: N/A Priority: Normal
NCT ID: NCT02856425 Org: User:
Start: 11/10/16 End: 11/30/28 Due: 11/30/29

Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02994576 Org: User:
Start: 12/12/16 End: 03/31/23 Due: 03/31/24

Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01486251 Org: User:
Start: 09/30/11 End: 09/30/14 Due: 09/30/15

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication

Phase: N/A Priority: Normal
NCT ID: NCT02233049 Org: User:
Start: 10/31/14 End: 10/31/18 Due: 10/31/19

Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood

Phase: N/A Priority: Normal
NCT ID: NCT00162695 Org: User:
Start: 07/31/95 End: - Due: -

Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03519048 Org: User:
Start: 01/17/18 End: 01/31/31 Due: 01/31/32

First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.

Phase: N/A Priority: Normal
NCT ID: NCT06840782 Org: User:
Start: 06/30/25 End: 02/28/30 Due: 02/28/31

Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC

Phase: N/A Priority: Normal
NCT ID: NCT00232960 Org: User:
Start: 10/31/05 End: 06/30/14 Due: 06/30/15

Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT03614936 Org: User:
Start: 06/11/13 End: 06/30/19 Due: 06/30/20

Prospective Study Assessing Thyroidectomy Using Robot

Phase: N/A Priority: Normal
NCT ID: NCT02839655 Org: User:
Start: 06/30/16 End: 08/31/22 Due: 08/31/23

Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics

Phase: N/A Priority: Normal
NCT ID: NCT02828462 Org: User:
Start: 10/24/16 End: 10/31/20 Due: 10/31/21

Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02105168 Org: User:
Start: 07/31/09 End: 07/31/19 Due: 07/31/20

Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab

Phase: N/A Priority: Normal
NCT ID: NCT01784900 Org: User:
Start: 11/30/12 End: 01/31/16 Due: 01/31/17